Search
Results : 2 ( "Biologics"[Keywords] ) AND "2023 ~ 2024"[Year]
-
Original ArticleJanuary 1, 2023
Treatment Sequence After Initiating Biologic Therapy for Patients With Rheumatoid Arthritis in Korea: A Nationwide Retrospective Cohort Study
Min Jung Kim
J Rheum Dis 2023; 30(1): 26-35
, M.D., Jun Won Park , M.D., Sun-Kyung Lee , Ph.D., Yumi Jang , MPH, Soyoung Kim , MPH, Matthias Stoelzel , Ph.D., Jonathan Lumen Chua , Ph.D., Kichul Shin , M.D., Ph.D. -
Review ArticleJanuary 1, 2023
Positive Effects of Biologics on Osteoporosis in Rheumatoid Arthritis
Yunkyung Kim
J Rheum Dis 2023; 30(1): 3-17, M.D., Ph.D., Geun-Tae Kim , M.D., Ph.D.
3
1908
454
Full Text
Cite
Share- 1
Oct 01, 2024
Vol.31 No.4, pp. 191~263
COVER PICTURE
Ancestry-driven pathways for SLE-risk SNP-associated genes. The ancestry-driven key signaling pathways in Asians, Europeans, and African Americans were analyzed by enrichr (https://maayanlab.cloud/Enrichr/#libraries) using non-HLA SNP-associated genes. SLE: systemic lupus
erythematosus, SNP: single-nucleotide polymorphism, JAK–STAT: janus kinase–signal transducers and activators of transcription, IFN: interferon gamma. (J Rheum Dis 2024;31:200-211)
